PHILADELPHIA — Adding the sex hormone estriol to glatiramer acetate (Copaxone, Teva Neuroscience), a drug indicated for the treatment of relapsing-remitting multiple sclerosis (RRMS), results in a ...

This month a UCLA researcher begins a widespread clinical trial of the female sex hormone estriol, produced during pregnancy, which she's shown sharply reduces the symptoms of multiple sclerosis. It ...

CLEVELAND, Ohio (March 29, 2017)--Pelvic organ prolapse is estimated to affect up to one-half of all women, causing pain and interfering with sexual function. A new study demonstrates how an ultralow ...

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of ...

A hormone common in pregnant women shows promise as an easily administered treatment for people with early-stage multiple sclerosis (MS). A new study by UCLA neuroscientists shows for the first time ...

Please provide your email address to receive an email when new articles are posted on . High levels of estriol may protect pregnant women in their third trimester from breast cancer, whereas elevated ...

Taking the pregnancy hormone estriol along with their conventional medications helped patients with relapsing-remitting multiple sclerosis (RRMS) avoid relapses, according to results of a Phase II ...

Cognitive deficits occur in over half of multiple sclerosis patients, with hippocampal-dependent learning and memory commonly impaired. Data from in vivo MRI and post-mortem studies in MS indicate ...

Please provide your email address to receive an email when new articles are posted on . Women with premature ovarian insufficiency prescribed oral hormone therapy were more likely to report increased ...

For decades, women with multiple sclerosis have noticed that they tend to do better while they are pregnant. That has led to an experimental drug for the disease that's based on a hormone associated ...